Acuitas, CureVac settle lawsuit over COVID-19 vaccine
Biotech company Acuitas Therapeutics and Germany-based CureVac have settled Acuitas' lawsuit demanding credit for inventions… Read More
5 months ago
CureVac
CureVac slashes COVID-19 vaccine production plans
German biotech firm CureVac said on Tuesday it cancelled contract manufacturing deals for its experimental… Read More
3 years ago
GSK, CureVac’s next-gen COVID-19 vaccine shows promise
GlaxoSmithKline and CureVac said a study on macaque monkeys showed their jointly-developed mRNA COVID-19 vaccine… Read More
3 years ago
CureVac fails in COVID-19 vaccine trial with 47% efficacy
German biotech CureVac said on Wednesday its COVID-19 vaccine was only 47% effective in a… Read More
3 years ago
GSK buys 10% of CureVac in vaccine tech deal
GSK and CureVac, backed by Microsoft billionaire Bill Gates, will work on developing up to… Read More
4 years ago
Germany takes 300 million euro stake in firm developing COVID-19 vaccine
The move was agreed with SAP co-founder Dietmar Hopp - who is an early backer… Read More
4 years ago